Dna Microarray Market
DNA Microarray Market Forecasts to 2030 - Global Analysis By Type (Oligonucleotide DNA Microarrays (oDNA), Complementary DNA Microarrays (cDNA) and Other Types), Technology, Application, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $3.7 BN |
|
Projected Year Value (2030) |
US $7.6 BN |
|
CAGR (2023 - 2030) |
10.7% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global DNA Microarray Market is accounted for $3.7 billion in 2023 and is expected to reach $7.6 billion by 2030 growing at a CAGR of 10.7% during the forecast period. A DNA microarray is a powerful tool used in molecular biology to simultaneously analyze the expression levels of thousands of genes in a single experiment. It consists of an arrayed series of microscopic spots containing DNA probes, each spot representing a specific gene or fragment of a gene. By hybridizing fluorescently labelled DNA or RNA samples onto these spots, scientists can detect and measure the expression levels of thousands of genes in a given sample, providing insights into gene function, regulation, and interactions within biological systems. This technology has been pivotal in fields like genomics, genetics, and biomedical research.
According to estimates by the Canadian Cancer Society, the country reported 233,900 new cancer cases with 85,100 deaths.
Market Dynamics:
Driver:
Advancements in genomics research
Genomics research within the DNA Microarray market has witnessed substantial advancements, revolutionizing personalized medicine and disease understanding. Innovations in microarray technology propel research in gene expression, mutation analysis, and genomic variations. Improved bioinformatics tools streamline data analysis, enabling comprehensive insights into complex biological systems. These advancements foster applications in clinical diagnostics, drug discovery, and biomarker identification, paving the way for precision medicine and targeted therapies.
Restraint:
Ethical and privacy concerns
DNA Microarrays pose ethical concerns due to potential misuse of genetic data, raising issues of privacy infringement, consent, and discrimination. The vast data collected can be exploited, compromising individuals' sensitive information without their informed consent. Additionally, concerns arise regarding the accuracy and interpretation of results, potentially impacting individuals' lives based on uncertain or misinterpreted genetic data. These are the factors restraining the growth of the segment.
Opportunity:
Rising demand for personalized medicine
The market is witnessing a surge in demand due to the growing interest in personalized medicine. This trend is fuelled by the technology's ability to analyze an individual's genetic makeup swiftly and accurately, enabling tailored treatment plans. As healthcare shifts toward precision medicine, these microarrays play a pivotal role by offering insights into genetic variations, aiding in targeted therapies, and enhancing patient outcomes. This rising demand underscores the pivotal role in advancing personalized healthcare solutions.
Threat:
High costs
The market has historically faced high costs due to intricate manufacturing processes, specialized equipment, and the need for precise quality control measures. These factors contribute to elevated expenses in raw materials, research, development, and production. Additionally, the complexity of the technology and the demand for accuracy and reliability further drives up costs, making microarrays a costly investment for research and diagnostic purposes.
Covid-19 Impact:
The COVID-19 pandemic triggered fluctuations in the DNA Microarray market. Initially, disruptions in supply chains and lab closures led to a slowdown. However, increased demand for diagnostics and research purposes, along with advancements in personalized medicine, boosted market growth. Rapid innovation and adaptation in technology for remote work and data analysis also influenced the market positively. Overall, the pandemic caused fluctuations but ultimately accelerated technological advancements and market expansion in applications.
The Pharmacogenomics segment is expected to be the largest during the forecast period
The pharmacogenomics segment is expected to be the largest during the forecast period. This segment utilizes DNA microarrays to identify genetic variations influencing drug metabolism, efficacy, and adverse reactions, guiding personalized treatment approaches. Its growth is driven by the demand for precision medicine, enabling tailored drug selection and dosing for better patient outcomes, making it a pivotal player in the healthcare industry's quest for personalized therapeutic interventions.
The diagnostic centers segment is expected to have the highest CAGR during the forecast period
The diagnostic centers segment is expected to have the highest CAGR during the forecast period. These centers employ microarrays to simultaneously examine numerous genes, identifying variations linked to illnesses. Advancements in microarray platforms enhance precision and throughput, fostering quicker diagnoses and personalized treatment strategies. This market segment thrives due to its pivotal role in decoding genetic information, driving innovation for targeted therapies and precise medical interventions.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. The region's market growth is propelled by rising investments in genomics, personalized medicine, and biotechnology. Factors such as increased adoption of advanced healthcare technologies, strategic collaborations, and a supportive regulatory environment contribute to the market's expansion, catering to diverse applications across research, diagnostics, and pharmaceutical industries.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period. The region's market witnesses escalating demand for personalized medicine, genetic research, and diagnostics, fostering market expansion. Key players, strategic collaborations, and government support for genomics research contribute to the market's steady rise. Moreover, growing awareness and adoption of genomic technologies among healthcare professionals and researchers further fuel the market's evolution in the region.
Key players in the market
Some of the key players in DNA Microarray market include Applied Micro Arrays, Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Merck KGaA, Agilent Technologies, Inc., Bio-Rad Laboratories, PerkinElmer, Oxford Gene Technology (OGT), Arrayit Corporation, Roche NimbleGen, Savyon Diagnostics, WaferGen Biosystems, Novacyt Group and Enzo Biochem, Inc.
Key Developments:
In August 2022, Thermo Fisher Scientific launched a new chromosomal microarray, the Applied Biosystem CytoScan HD Accel array, to improve cytogenetic research lab productivity, efficiency, and profitability with two-day turnaround time. This strategy helped the company to expand their product portfolio.
In May 2022, Qatar Genome Program and Thermo Fisher Scientific announced a partnership to accelerate genomic research and clinical applications of predictive genomics in Qatar.
Types Covered:
• Oligonucleotide DNA Microarrays (oDNA)
• Complementary DNA Microarrays (cDNA)
• Other Types
Technologies Covered:
• Inkjet
• Microfluidics
• Hybridization
• Other Technologies
Applications Covered:
• Gene Expression Analysis
• Cancer Research
• Genotyping
• Genetics
• Drug Discovery
• Forensic Science
• Neuroscience
• Other Applications
End Users Covered:
• Contract Research Organizations (CROs)
• Biotechnology Companies
• Hospitals and Clinics
• Academic and Research Institutes
• Diagnostic Centers
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global DNA Microarray Market, By Type
5.1 Introduction
5.2 Oligonucleotide DNA Microarrays (oDNA)
5.3 Complementary DNA Microarrays (cDNA)
5.4 Other Types
6 Global DNA Microarray Market, By Technology
6.1 Introduction
6.2 Inkjet
6.3 Microfluidics
6.4 Hybridization
6.5 Other Technologies
7 Global DNA Microarray Market, By Application
7.1 Introduction
7.2 Gene Expression Analysis
7.3 Cancer Research
7.4 Genotyping
7.5 Genetics
7.6 Drug Discovery
7.7 Forensic Science
7.8 Neuroscience
7.9 Other Applications
8 Global DNA Microarray Market, By End User
8.1 Introduction
8.2 Contract Research Organizations (CROs)
8.3 Biotechnology Companies
8.4 Hospitals and Clinics
8.5 Academic and Research Institutes
8.6 Diagnostic Centers
8.7 Other End Users
9 Global DNA Microarray Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Applied Micro Arrays
11.2 Illumina, Inc.
11.3 QIAGEN
11.4 F. Hoffmann-La Roche Ltd.
11.5 Thermo Fisher Scientific, Inc.
11.6 PerkinElmer, Inc.
11.7 Merck KGaA
11.8 Agilent Technologies, Inc.
11.9 Bio-Rad Laboratories
11.10 PerkinElmer
11.11 Oxford Gene Technology (OGT)
11.12 Arrayit Corporation
11.11 Roche NimbleGen
11.14 Savyon Diagnostics
11.15 WaferGen Biosystems
11.16 Novacyt Group
11.17 Enzo Biochem, Inc.
List of Tables
1 Global DNA Microarray Market Outlook, By Region (2021-2030) ($MN)
2 Global DNA Microarray Market Outlook, By Type (2021-2030) ($MN)
3 Global DNA Microarray Market Outlook, By Oligonucleotide DNA Microarrays (oDNA) (2021-2030) ($MN)
4 Global DNA Microarray Market Outlook, By Complementary DNA Microarrays (cDNA) (2021-2030) ($MN)
5 Global DNA Microarray Market Outlook, By Other Types (2021-2030) ($MN)
6 Global DNA Microarray Market Outlook, By Technology (2021-2030) ($MN)
7 Global DNA Microarray Market Outlook, By Inkjet (2021-2030) ($MN)
8 Global DNA Microarray Market Outlook, By Microfluidics (2021-2030) ($MN)
9 Global DNA Microarray Market Outlook, By Hybridization (2021-2030) ($MN)
10 Global DNA Microarray Market Outlook, By Other Technologies (2021-2030) ($MN)
11 Global DNA Microarray Market Outlook, By Application (2021-2030) ($MN)
12 Global DNA Microarray Market Outlook, By Gene Expression Analysis (2021-2030) ($MN)
13 Global DNA Microarray Market Outlook, By Cancer Research (2021-2030) ($MN)
14 Global DNA Microarray Market Outlook, By Genotyping (2021-2030) ($MN)
15 Global DNA Microarray Market Outlook, By Genetics (2021-2030) ($MN)
16 Global DNA Microarray Market Outlook, By Drug Discovery (2021-2030) ($MN)
17 Global DNA Microarray Market Outlook, By Forensic Science (2021-2030) ($MN)
18 Global DNA Microarray Market Outlook, By Neuroscience (2021-2030) ($MN)
19 Global DNA Microarray Market Outlook, By Other Applications (2021-2030) ($MN)
20 Global DNA Microarray Market Outlook, By End User (2021-2030) ($MN)
21 Global DNA Microarray Market Outlook, By Contract Research Organizations (CROs) (2021-2030) ($MN)
22 Global DNA Microarray Market Outlook, By Biotechnology Companies (2021-2030) ($MN)
23 Global DNA Microarray Market Outlook, By Hospitals and Clinics (2021-2030) ($MN)
24 Global DNA Microarray Market Outlook, By Academic and Research Institutes (2021-2030) ($MN)
25 Global DNA Microarray Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
26 Global DNA Microarray Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
